tirzepatide for alcohol use disorder The latest AAAP podcast episode is live! 🎙️ Could medications like semaglutide and become a new tool in treating Disorder? In this episode, hosts Danae DiRocco, MD, MPH and Anti-consumption agents: Tirzepatide and semaglutide

GLP-1 receptor agonists work by slowing stomach emptying, reducing appetite, and regulating blood sugar and in doing so, they can influence almost every system in the body

Among 36 participants with CGM data available, time in range with glucose between 70 mg/dL and 180 mg/dL increased from 55.1% at baseline to 62.3% at 6 months ( P = .022)

The Double Bone Density Problem Ready to Get Strong with Us

4e), inguinal WAT (Fig

Contact the prescriber and pharmacist when the product or dosage form changes

Today we feature a pair of studies that took a deeper dive into the effects of GLP-1 drugs being widely used for weight loss and diabetes